MARKET PULSE-Oramed, Theravance, Oracle, Wilan, Ebix, Idenix

Fri Jun 21, 2013 1:19pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/saw98t)

June 21 (Reuters) - Some U.S. stocks on the move on Friday:

WALL ST REBOUND FADES, ORACLE DRAGS ON NASDAQ

U.S. stocks turned lower as the initial bounce from a two-day selloff faded and banking stocks fell, while a sharp drop in Oracle shares dragged down the Nasdaq. The Dow Jones industrial average was down 0.2 percent, the Standard & Poor's 500 Index down 0.39 percent and the Nasdaq Composite Index down 0.81 percent.

** IDENIX PHARMACEUTICALS INC, $3.39, down 34 pct (0930 ET)

Idenix Pharmaceuticals said it expects a delay in human trials of one of its experimental hepatitis C drugs after the U.S. Food and Drug Administration asked for additional safety data.

  Continued...